Drug Interactions between E-Mycin and Keflex
This report displays the potential drug interactions for the following 2 drugs:
- E-Mycin (erythromycin)
- Keflex (cephalexin)
Interactions between your drugs
No interactions were found between E-Mycin and Keflex. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
A total of 560 drugs are known to interact with E-Mycin.
- E-mycin is in the drug class macrolides.
E-mycin is used to treat the following conditions:
- Bacterial Endocarditis Prevention
- Bowel Preparation
- Bullous Pemphigoid
- Campylobacter Gastroenteritis
- Chlamydia Infection
- Dental Abscess
- Legionella Pneumonia
- Lyme Disease
- Lymphogranuloma Venereum
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Otitis Media
- Rheumatic Fever Prophylaxis
- Skin or Soft Tissue Infection
- Strep Throat
- Syphilis, Early
- Upper Respiratory Tract Infection
- Keflex is in the drug class first generation cephalosporins.
- Keflex is used to treat the following conditions:
Drug and food interactions
Applies to: E-Mycin (erythromycin)
Food decreases the levels of erythromycin in your body. Take erythromycin on an empty stomach at least 30 minutes before or 2 hours after a meal. This will make it easier for your body to absorb the medication. However, some erythromycin products may be taken without regard to meals. Ask your healthcare provider about your particular prescription if you are uncertain of how to take it. Grapefruits and grapefruit juice may increase erythromycin levels but how this may affect you is not known. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|